biotech market strategy

Gene therapy commercialization strategies in 2026 are entering a more disciplined phase as US biotech companies transition from scientific validation to scalable market execution. Following a decade marked by breakthrough approvals and record venture inflows, the commercial environment now demands operational maturity, reimbursement clarity, and sustainable manufacturing economics. Companies developing one-time, high-cost therapies must balance … Read more